Government decides to discontinue the Central Allocation of Remdesivir
Press Releases (Remdesivir)
-
-
Swift actions taken by Government to enhance availability of Remdesivir in India
-
India to import 4,50,000 vials of Remdesivir
-
25 new manufacturing sites approved for Remdesivir production
-
Union Government allocates supply of Remdesivir to 19 States/UTs with High Burden of COVID cases
-
Finance Minister Nirmala Sitharaman assures ramp up in supply of Oxygen & Remdesivir to States
-
Jubilant Pharmova’s subsidiary, Jubilant Pharma, announces the development of a novel oral formulation of Remdesivir
-
Hetero announces the approval and launch of first generic ‘COVIFOR’ (Remdesivir) in India for the treatment of Covid-19
